Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services.

Psychiatry Res

Research and Development Department, North East London NHS Foundation Trust (NELFT), Goodmayes Hospital, Ilford, UK; Division of Psychiatry, University College London, 149 Tottenham Court Road, London, UK, (Honorary for MAH).

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Previous studies of antidepressant withdrawal have been limited by short duration of drug exposure or self-selected samples. Our study aimed to estimate withdrawal effects in routine clinical practice.

Methods: Participants from NHS primary care psychological treatment services who had ever tried to stop an antidepressant were surveyed. Regression models were constructed to examine the association between personal and medication characteristics, and withdrawal.

Results: Respondents(n = 310) were mostly female(78 %), white(75 %), with an average age of 38.79(SD 12.4). The response rate was 18 % of eligible patients. 62 % reported antidepressants had been helpful. Withdrawal symptoms of some degree were reported by 79 %. 45 % reported severe or moderately severe symptoms. 43 % met the most stringent definition of a withdrawal syndrome, reporting 4 or more 'non-emotional' withdrawal symptoms. 38 % of participants reported being unable to stop their antidepressant when they tried to do so. 20 % reported withdrawal symptoms lasting more than three months and 10 % for more than a year. In fully adjusted models those using antidepressants for over 24-months prior to stopping were more likely to experience a withdrawal syndrome (OR(95 %CI)=10.41(2.88;37.67)), report severe withdrawal effects (OR(95 %CI) = 5.16(2.75;9.70)), report longer lasting symptoms (Beta(95 %CI)=18.11(3.85;32.38), and be less likely to be able to stop (OR(95 %CI)=27.55(10.29;73.81), than those using for less than six-months.

Conclusion: Antidepressant withdrawal symptoms were common, and severe and prolonged for a substantial proportion of users. Longer duration of use was associated with greater likelihood of severe and protracted symptoms and being less likely to be able to stop. A limitation of this study is the low rate of response.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2025.116497DOI Listing

Publication Analysis

Top Keywords

withdrawal symptoms
16
withdrawal effects
12
withdrawal
9
primary care
8
antidepressant withdrawal
8
withdrawal syndrome
8
symptoms
7
reported
5
severe
5
antidepressants withdrawal
4

Similar Publications

Background: Hikikomori, characterized by prolonged social withdrawal and isolation, is often comorbid with psychiatric conditions including depression and anxiety. While cross-sectional studies consistently link hikikomori with depressive symptoms, the directionality of this relationship remains unclear because longitudinal evidence is lacking.

Objective: This study examined the longitudinal association between depressive symptoms and hikikomori behavioral tendencies, focusing on both the topography (observable features) and functions of hikikomori behaviors, as conceptualized in operant conditioning theory.

View Article and Find Full Text PDF

Background: Bipolar disorder (BD) is a complex mood disorder among the leading causes of disability worldwide. Internalized stigma refers to the awareness of negative stereotypes adopted by society and the agreement with these judgments, often associated with impaired functionality and social adaptation. Studies examining internalized stigma and related factors in BD are limited.

View Article and Find Full Text PDF

Drug-induced immune thrombocytopenia (DITP) is a rare but life-threatening condition characterized by a sudden and serious drop in the number of platelets from drug-dependent antibodies against platelet glycoproteins. We report the case of a 57-year-old man who developed severe thrombocytopenia and mucocutaneous bleeding following a short course of trimethoprim-sulfamethoxazole (TMP-SMX) for presumed tick-borne disease. The patient experienced bleeding gums, pinpoint rashes, bruising, and extreme fatigue.

View Article and Find Full Text PDF

Background: The benefits of phosphodiesterase-5 inhibitors in the treatment of sexual dysfunction and psychopathology of schizophrenia remain unclear. This systematic review and meta-analysis aimed to address the above clinical question.

Methods: Our primary outcome includes erectile dysfunction (ED) assessed using standardized questionnaires.

View Article and Find Full Text PDF

Problematic mobile phone use (PMPU) has become increasingly prevalent among young adults, raising concerns about its psychological underpinnings. While shyness has been linked to PMPU, few studies have explored the symptom-level mechanisms that differentiate problematic from non-problematic users. This study employed psychological network analysis to examine the structure and central symptoms of PMPU in two groups: problematic and non-problematic mobile phone users.

View Article and Find Full Text PDF